Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 110
- Uncategorized
Chuck Schumer Says Lawmakers Will Prioritise ‘Making Progress’ on SAFE Banking Act Amid Return From Summer Recess
On Tuesday, as the US senate returned from its August recess, the majority leader Chuck Schumer reiterated his commitment to advancing the highly anticipated Secure and Fair Enforcement (SAFE) Banking Act.
- Uncategorized
US recommendation to reschedule cannabis marks ‘significant shift in drug policy’ and ‘new opportunities’ for industry
The US Department of Health and Human Services (HHS) recommendation to reschedule cannabis marks a significant shift in drug policy, untangling decades of prohibition and offering new opportunities for the industry, writes FoxNRTH’s Principal, Chris Murray.
- Opinion
Switzerland’s ‘Pragmatic Not Political’ Approach To Cannabis Reform Should Set Precedent
Last week saw the launch of ZüriCan, Switzerland’s second cannabis pilot set to give over 2000 Zurich inhabitants legal access to adult-use cannabis.
- CBD Market
Italy’s CBD Industry Faces New Blow as Government Decrees CBD Oil as Narcotic Substance
Italy’s government has taken aim at CBD once again, issuing a new decree set to class CBD oil as a narcotic substance.
- Markets & Stocks
MGC Pharma Raises A$834k in Share Purchase Plan, & More From DanCann Pharma
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals announced the closure of its share purchase plan (SPP) this week, seeing the company successfully raise a further A$834k (£426k).
- Data & Analysis
Pharmaceutical Cannabis Players Are Driving Technological Innovation Across The Value Chain
The slow but steady march of pharmaceutical players into the cannabis industry has spurned a new period of technological innovation, bringing new techniques and technologies to every part of the cannabis value chain.
- Press releases
Mamedica Launches First Own-Brand Strains of Canadian THC-Dominant Cannabis in the UK With Cantourage
Mamedica® – the UK’s fastest-growing medical cannabis clinic, has partnered with Cantourage UK to launch the first of its own-branded products in the UK.
- Data & Analysis
Canadian Medical Cannabis Exports Jump 50% Amid Decreasing Domestic Sales
Canadian cannabis companies are increasingly turning to the international medical cannabis market, seeing exports increase by 50% last year.
- Uncategorized
Ron DeSantis Doubles Down on Hardline Anti-Cannabis Stance Claiming Legalisation ‘Hasn’t Worked’
Republican presidential hopeful Ron DeSantis has doubled down on his anti-cannabis position, stating once again that he had no plans for federal legislation and that ‘drugs are killing this country’.
- CBD Market
#SaveOurCBD Campaign Calls on the Home Office to Protect CBD Industry and Reassure Millions of Consumers
The UK consumer cannabinoid industry today issued an urgent plea calling on the Home Office to put in place a legal framework to cover the sale of CBD products – something which it committed to doing in January 2021.
- Uncategorized
Number of US States Topping $1bn in Cannabis Sales To Drop This Year
The number of US states to have legalised adult-use cannabis predicted to achieve total sales of over $1bn has fallen this year, according to new figures from Cannabis Business Times.
- Uncategorized
New Jersey Cannabis Industry Stuck in ‘Doom Loop’ Says New Report
The New Jersey Cannabis Trade Association (NJCTA), one of the state’s leading trade organisations, says that a lack of enforcement, thriving illicit market, and overregulation are killing the local legal cannabis industry.











